Animal rabies control has been frustrated by the existence of multiple wildlife reservoirs and the lack of efficacious oral vaccines. In this investigation, raccoons fed a vaccinia-rabies glycoprotein recombinant virus in a sponge bait developed rabies virus-neutralizing antibody (0.6-54.0 units) and resisted street rabies virus infection 28 and 205 days after feeding. Additional raccoons immunized by oral infusion with attenuated antigenic variants of rabies virus strains CVS-11 and ERA failed to develop rabies virus-neutralizing antibody. This work demonstrates the feasibility of a recombinant virus vaccine containing the rabies glycoprotein gene for immunization of raccoons, and possibly other wildlife, to obtain longterm protection against rabies.
Annually, 25,000-30,000 humans in the U.S. are treated for possible rabies virus infection after exposure to known or suspected rabid animals. Infected wildlife constitute a significant reservoir of rabies virus for humans and domestic animals alike (1); therefore, a major aim toward control of sylvatic rabies has been to develop an efficacious, safe, and economical oral rabies vaccine suitable for effective field distribution. Initially, the red fox (Vulpes vulpes) was the predominant target for oral immunization (2) (3) (4) (5) , with protection demonstrated both in the laboratory and in European field trials. While these studies provided encouraging results, other species (e.g., the striped skunk Mephitis mephitis and the raccoon Procyon lotor), which are major rabies virus vectors within North America (6) , have been refractory to efficient oral immunization against rabies (7). Due to a major rabies epizootic among raccoons in the mid-Atlantic region of the U.S. (8) , we have focused on the need to test new vaccines and immunization protocols for wildlife species. In this report, we describe results that indicate long-term protection against rabies in raccoons immunized with a recombinant virus vaccine containing only the rabies virus glycoprotein gene as exogenous DNA.
MATERIALS AND METHODS
Virus Strains. Attenuated antigenic variant viruses of rabies CVS-11 (9) and ERA (10) (17) ; this sponge is under consideration as a vaccine field deployment bait (18) . Thirteen control animals received a comparable volume of cell culture medium in a bait (sham immunization). A bait was placed in each cage, and after 48 hr untouched bait was removed. Any animal not eating a bait within this period was given 1.0 ml of either 108 or 106 pfu of V-RG virus by oral infusion, as described above. Blood was collected from all animals at the time of immunization and 16-28 days later. Rabies virus-neutralizing antibody levels were determined in vitro by a modification of the standard rapid fluorescent focus inhibition test (19, 20) . Titers were expressed in units/ml using the National Institutes of Health reference serum (lot R-3) as standard.
Virus Challenge and Post-Mortem Evaluation. V-RG virustreated and sham-immunized animals were challenged 28 or 205 days after immunization with 0. fTo whom reprint requests should be addressed.
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and virus isolation techniques as described (21) . Survivors were bled for rabies virus-neutralizing antibody determination at 30 and 90 days after challenge, at which time they were euthanatized. Post-mortem examination was not done on animals found dead, but on those euthanatized either while in terminal stages of rabies virus infection or after surviving to the end of the experimental period. Brain and other tissue samples of representative major organs (excluding bone) were fixed in 10% (vol/vol) buffered formalin, embedded in paraffin, sectioned at 6 ,um, and stained with hematoxylin and eosin prior to examination by light microscopy.
RESULTS
Induction of Virus-Neutralizing Antibody by Oral Immunization. Six raccoons treated orally with attenuated rabies variant (CVS-11 RV194-2 or ERA RV194-2) viruses did not develop detectable rabies virus-neutralizing antibody 28 days following treatment, as compared to sham-immunized controls (<0.3 unit/ml). These raccoons were, therefore, not studied further. Of twenty raccoons given V-RG virus in sponge bait, two (raccoons 40 and 41) did not ingest bait within 48 hr of presentation. Raccoon 40 was then given an oral infusion of 106 pfu/ml V-RG virus, and animal 41 received 108 pfu/ml by the same method. All animals developed rabies virus-neutralizing antibody following oral infusion or by ingestion of bait containing V-RG virus. By 16-28 days after immunization titers varied from 0.6 to 54.0 units/ml (Tables 1 and 2 ). Since all animals showed titers of less than 0.3 unit/ml before vaccination, titers of 0.6 unit/ml were considered positive in response to V-RG virus. Animals receiving vaccine by oral infusion responded as well as raccoons actually consuming vaccine in sponge baits.
Response DISCUSSION These data clearly demonstrate that V-RG virus administered orally to raccoons in a sponge bait may induce high levels of circulating rabies virus-neutralizing antibody and may protect raccoons for a minimum of six months after immunization against a virulent street rabies virus challenge. Attenuated rabies viruses (using antigenic variants CVS RV194-2 and ERA RV 194-2) were ineffective in generating a serological response in raccoons when administered orally. In contrast, live attenuated ERA virus vaccine (10) (106.5 MICLD50 per ml) has been shown to induce virus-neutralizing antibody and protect foxes from rabies when administered by a sponge bait (18) This study also shows that a minimum virus-neutralizing antibody titer is not widely applicable as an indication of adequate animal vaccination, especially in wildlife species, unlike the arbitrarily defined level of 0.5 unit/ml in humans, which is considered indicative of successful rabies immunization (22) . As an illustration, raccoon 40 had a virusneutralizing antibody titer of 1.3 units/ml at the time of challenge but died following inoculation with rabies virus, whereas raccoons 56 and 57 survived challenge with virusneutralizing antibody titers of 0.6 unit/ml. Other raccoons, immunized i.m. or orally with V-RG, or parenterally with live ERA RV 194-2 virus, died following rabies inoculation despite titers in the range of 0.6-9.0 units/ml on the day of challenge (C.E.R., unpublished data). Clearly, virus-neutralizing antibody titer alone is unsuitable as the sole criterion of successful rabies immunization. A protective index may be defined for a particular study, but other factors besides specific humoral responses are important in host defense against rabies (23) . It remains uncertain whether a minimum virus-neutralizing antibody titer can be correlated with protection.
The rabies virus strain used for experimental raccoon infection in this study was 
